Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy

Cristiana ErcolaniDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Anna Di BenedettoDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Irene TerrenatoBiostatistics-Scientific Direction, “Regina Elena” National Cancer Institute, Via Elio Chianes, Rome, Italy

Laura PizzutiDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Luigi Di LauroDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Domenico SergiDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Francesca SperatiBiostatistics-Scientific Direction, “Regina Elena” National Cancer Institute, Via Elio Chianes, Rome, Italy

Simonetta BuglioniDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Maria Teresa RamieriDivision of Pathology, ASL Frosinone, Via Armando Fabi, Frosinone, Italy

Lucia MentucciaMedical Oncology Unit, ASL Frosinone, Frosinone, Via Armando Fabi, Frosinone, Italy

Teresa GamucciMedical Oncology Unit, ASL Frosinone, Frosinone, Via Armando Fabi, Frosinone, Italy

Letizia PerracchioDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Edoardo PescarmonaDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Marcella MottoleseDepartment of Pathology, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Maddalena BarbaDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy;Scientific Direction, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Patrizia ViciDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy

Ruggero De MariaInstitute of General Pathology, Catholic University of the Sacred Heart, Largo Agostino Gemelli, Rome, Italy

Marcello Maugeri-SaccàDivision of Medical Oncology 2, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, Italy;Scientific Direction, “Regina Elena” National Cancer Institute, Via Elio Chianesi, Rome, ItalyCorrespondence[email protected] [email protected]

show all

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date